| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UKNOWN |
| UNII: | S9OX9692ZB |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | T-lymphocyte activation antigen CD80 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109191 |
| FDA SRS | S9OX9692ZB |
CONTENTS